This exploration was completed To guage the potential on the CPPs with tumor-focusing on Qualities to provide a cytotoxic payload to HCC cells. We explored utilizing a CXCR4-targeting peptide, T22, fused with cytotoxic peptide PE24, to be a novel therapeutic approach for CXCR4+ HCC cells. T22 was decided on because https://margareta963lpt4.newsbloger.com/profile